Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.7600
- TODAY'S CHANGE (%)0.1100 (1.4379%)
- Bid / Lots7.6200/ 3
- Ask / Lots7.8500/ 1
- Open / Previous Close7.6500 / 7.6500
- Day Range
- 52 Week Range
- Volume742,479
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 5098 | 7.6473 |
| 09:34 ET | 1224 | 7.71 |
| 09:36 ET | 2808 | 7.74 |
| 09:38 ET | 100 | 7.705 |
| 09:41 ET | 2879 | 7.65 |
| 09:43 ET | 2010 | 7.65 |
| 09:45 ET | 2406 | 7.6014 |
| 09:50 ET | 2240 | 7.635 |
| 09:52 ET | 464 | 7.61 |
| 09:54 ET | 158 | 7.63 |
| 09:56 ET | 300 | 7.61 |
| 09:57 ET | 100 | 7.61 |
| 09:59 ET | 6897 | 7.66 |
| 10:01 ET | 2900 | 7.64 |
| 10:03 ET | 100 | 7.64 |
| 10:06 ET | 2492 | 7.66 |
| 10:08 ET | 4490 | 7.69 |
| 10:10 ET | 3227 | 7.705 |
| 10:12 ET | 4426 | 7.755 |
| 10:14 ET | 2390 | 7.73 |
| 10:15 ET | 674 | 7.74 |
| 10:17 ET | 2819 | 7.74 |
| 10:19 ET | 3163 | 7.715 |
| 10:21 ET | 600 | 7.715 |
| 10:24 ET | 1510 | 7.71 |
| 10:26 ET | 2336 | 7.7 |
| 10:28 ET | 200 | 7.68 |
| 10:30 ET | 800 | 7.68 |
| 10:32 ET | 500 | 7.67 |
| 10:33 ET | 1414 | 7.69 |
| 10:35 ET | 1462 | 7.67 |
| 10:37 ET | 1269 | 7.65 |
| 10:39 ET | 1333 | 7.67 |
| 10:42 ET | 700 | 7.66 |
| 10:44 ET | 300 | 7.66 |
| 10:46 ET | 1648 | 7.67 |
| 10:48 ET | 100 | 7.68 |
| 10:50 ET | 129 | 7.6972 |
| 10:51 ET | 2149 | 7.699 |
| 10:53 ET | 300 | 7.68 |
| 10:55 ET | 6651 | 7.67 |
| 10:57 ET | 600 | 7.67 |
| 11:00 ET | 837 | 7.67 |
| 11:02 ET | 6677 | 7.71 |
| 11:04 ET | 5734 | 7.76 |
| 11:06 ET | 2750 | 7.74 |
| 11:08 ET | 600 | 7.73 |
| 11:09 ET | 1400 | 7.71 |
| 11:11 ET | 2223 | 7.71 |
| 11:13 ET | 800 | 7.715 |
| 11:15 ET | 100 | 7.72 |
| 11:18 ET | 700 | 7.72 |
| 11:20 ET | 1310 | 7.71 |
| 11:22 ET | 2959 | 7.725 |
| 11:24 ET | 800 | 7.72 |
| 11:26 ET | 1070 | 7.72 |
| 11:27 ET | 1200 | 7.71 |
| 11:29 ET | 600 | 7.71 |
| 11:31 ET | 900 | 7.69 |
| 11:33 ET | 1400 | 7.695 |
| 11:36 ET | 700 | 7.7 |
| 11:38 ET | 100 | 7.695 |
| 11:40 ET | 100 | 7.695 |
| 11:42 ET | 884 | 7.685 |
| 11:44 ET | 600 | 7.675 |
| 11:45 ET | 1000 | 7.68 |
| 11:47 ET | 2249 | 7.67 |
| 11:49 ET | 200 | 7.67 |
| 11:51 ET | 1702 | 7.665 |
| 11:54 ET | 900 | 7.675 |
| 11:56 ET | 2132 | 7.675 |
| 11:58 ET | 401 | 7.69 |
| 12:00 ET | 200 | 7.69 |
| 12:02 ET | 300 | 7.69 |
| 12:03 ET | 1835 | 7.695 |
| 12:05 ET | 699 | 7.695 |
| 12:07 ET | 400 | 7.69 |
| 12:09 ET | 1051 | 7.705 |
| 12:12 ET | 2000 | 7.7 |
| 12:14 ET | 6019 | 7.745 |
| 12:16 ET | 3199 | 7.745 |
| 12:18 ET | 500 | 7.74 |
| 12:20 ET | 427 | 7.745 |
| 12:21 ET | 776 | 7.755 |
| 12:23 ET | 600 | 7.765 |
| 12:25 ET | 893 | 7.765 |
| 12:27 ET | 300 | 7.775 |
| 12:30 ET | 4392 | 7.755 |
| 12:32 ET | 3334 | 7.745 |
| 12:34 ET | 500 | 7.74 |
| 12:36 ET | 2121 | 7.755 |
| 12:38 ET | 2713 | 7.75 |
| 12:39 ET | 2948 | 7.75 |
| 12:41 ET | 300 | 7.74 |
| 12:43 ET | 1129 | 7.73 |
| 12:45 ET | 800 | 7.74 |
| 12:48 ET | 1300 | 7.735 |
| 12:50 ET | 400 | 7.73 |
| 12:52 ET | 5390 | 7.76 |
| 12:54 ET | 7260 | 7.74 |
| 12:56 ET | 2160 | 7.76 |
| 12:57 ET | 2000 | 7.775 |
| 12:59 ET | 4765 | 7.78 |
| 01:01 ET | 751 | 7.775 |
| 01:03 ET | 1400 | 7.765 |
| 01:06 ET | 1844 | 7.77 |
| 01:08 ET | 600 | 7.765 |
| 01:10 ET | 3410 | 7.78 |
| 01:12 ET | 3220 | 7.775 |
| 01:14 ET | 2596 | 7.77 |
| 01:15 ET | 800 | 7.77 |
| 01:17 ET | 400 | 7.78 |
| 01:19 ET | 3055 | 7.77 |
| 01:21 ET | 964 | 7.78 |
| 01:24 ET | 3236 | 7.79 |
| 01:26 ET | 1030 | 7.795 |
| 01:28 ET | 2036 | 7.81 |
| 01:30 ET | 2003 | 7.795 |
| 01:32 ET | 500 | 7.78 |
| 01:33 ET | 500 | 7.78 |
| 01:35 ET | 1049 | 7.78 |
| 01:37 ET | 999 | 7.775 |
| 01:39 ET | 400 | 7.77 |
| 01:42 ET | 400 | 7.7789 |
| 01:44 ET | 2980 | 7.78 |
| 01:46 ET | 983 | 7.79 |
| 01:48 ET | 900 | 7.795 |
| 01:50 ET | 2175 | 7.795 |
| 01:51 ET | 300 | 7.8 |
| 01:53 ET | 1169 | 7.8 |
| 01:55 ET | 765 | 7.81 |
| 01:57 ET | 589 | 7.815 |
| 02:00 ET | 3339 | 7.8 |
| 02:02 ET | 700 | 7.79 |
| 02:04 ET | 1500 | 7.765 |
| 02:06 ET | 500 | 7.76 |
| 02:08 ET | 600 | 7.77 |
| 02:09 ET | 600 | 7.76 |
| 02:11 ET | 1993 | 7.765 |
| 02:13 ET | 765 | 7.7665 |
| 02:15 ET | 960 | 7.775 |
| 02:18 ET | 1910 | 7.765 |
| 02:20 ET | 2346 | 7.75 |
| 02:22 ET | 1232 | 7.735 |
| 02:24 ET | 775 | 7.72 |
| 02:26 ET | 1512 | 7.735 |
| 02:27 ET | 300 | 7.735 |
| 02:31 ET | 576 | 7.735 |
| 02:33 ET | 500 | 7.735 |
| 02:36 ET | 1936 | 7.735 |
| 02:38 ET | 400 | 7.735 |
| 02:40 ET | 3642 | 7.71 |
| 02:42 ET | 1000 | 7.725 |
| 02:44 ET | 1174 | 7.73 |
| 02:45 ET | 1194 | 7.72 |
| 02:47 ET | 678 | 7.715 |
| 02:49 ET | 300 | 7.715 |
| 02:51 ET | 2730 | 7.71 |
| 02:54 ET | 800 | 7.705 |
| 02:56 ET | 100 | 7.7 |
| 02:58 ET | 2004 | 7.715 |
| 03:00 ET | 1333 | 7.71 |
| 03:02 ET | 1696 | 7.73 |
| 03:03 ET | 1375 | 7.73 |
| 03:05 ET | 1766 | 7.74 |
| 03:07 ET | 1208 | 7.7399 |
| 03:09 ET | 501 | 7.745 |
| 03:12 ET | 500 | 7.745 |
| 03:14 ET | 1000 | 7.745 |
| 03:16 ET | 1334 | 7.745 |
| 03:18 ET | 200 | 7.75 |
| 03:20 ET | 2946 | 7.745 |
| 03:21 ET | 951 | 7.745 |
| 03:23 ET | 801 | 7.755 |
| 03:25 ET | 564 | 7.755 |
| 03:27 ET | 10328 | 7.76 |
| 03:30 ET | 1410 | 7.76 |
| 03:32 ET | 9523 | 7.75 |
| 03:34 ET | 478 | 7.765 |
| 03:36 ET | 1022 | 7.76 |
| 03:38 ET | 2905 | 7.76 |
| 03:39 ET | 10001 | 7.78 |
| 03:41 ET | 1973 | 7.78 |
| 03:43 ET | 3544 | 7.77 |
| 03:45 ET | 1995 | 7.78 |
| 03:48 ET | 1997 | 7.785 |
| 03:50 ET | 1859 | 7.795 |
| 03:52 ET | 7032 | 7.78 |
| 03:54 ET | 11515 | 7.76 |
| 03:56 ET | 12362 | 7.755 |
| 03:57 ET | 10364 | 7.755 |
| 03:59 ET | 152168 | 7.76 |
Sep 4, 2024
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031, from 8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
Aug 22, 2024
Vir Biotechnology to Participate in the Morgan Stanley 22(nd) Annual Global Healthcare Conference, from 8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
Aug 20, 2024
DJ Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co., from 6:29AM ET on Tuesday Aug 20, 2024 by Dow Jones
6:29AM ET on Tuesday Aug 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.1B | -2.2x | --- |
Prothena Corporation PLC | 1.1B | -20.1x | --- |
Gyre Therapeutics Inc | 1.2B | -14.5x | --- |
Zymeworks Inc | 821.3M | -7.6x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.7x | --- |
Silence Therapeutics PLC | 870.2M | -15.4x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 13.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
